Add BrightSurf on Google Email

Science News for June 24, 2004


Call for removal of Crestor

Rosuvastatin, marketed as Crestor, has been linked to a higher incidence of rhabdomyolysis and renal insufficiency compared to other statins. The drug's manufacturer, AstraZeneca, is estimated to be seeking $20 billion in annual sales, making it morally unjustifiable to keep the drug on the market.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 24, 2004

Helping employees cope with aggressive customers

A recent study found that employees who were allowed to regulate their emotions in response to customer aggression reported lower levels of stress. Employers are advised to provide training in emotional regulation for service representatives to reduce burnout and absenteeism. The researchers also recommended enhancing job autonomy to m...

SourcePenn State·JournalJournal of Organizational Behavior·DateJun 24, 2004

Bad teeth blamed on unhealthy adult lifestyle

A study by Newcastle University found that adult smokers are more likely to experience tooth loss. Adults from disadvantaged social backgrounds also suffered from oral health problems. The research suggests that public health interventions should target adults as well, in addition to children.

SourceNewcastle University·JournalJournal of Dental Research·DateJun 24, 2004